TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Urogyn Sverige AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/08 |
| Turnover |
2,813
|
3,495
|
2,904 |
| Financial expenses |
454
|
42
|
13 |
| Earnings before taxes |
-5,726
|
-337
|
3,442 |
| EBITDA |
-29,401
|
-27,713
|
-13,868 |
| Total assets |
15,557
|
14,332
|
12,445 |
| Current assets |
3,721
|
4,333
|
7,328 |
| Current liabilities |
5,159
|
4,964
|
1,971 |
| Equity capital |
1,120
|
6,178
|
9,497 |
| - share capital |
65
|
67
|
70 |
| Employees (average) |
6
|
23
|
14 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/08 |
| Solvency |
7.2%
|
43.1%
|
76.3% |
| Turnover per employee |
469
|
152
|
207 |
| Profit as a percentage of turnover |
-203.6%
|
-9.6%
|
118.5% |
| Return on assets (ROA) |
-33.9%
|
-2.1%
|
27.8% |
| Current ratio |
72.1%
|
87.3%
|
371.8% |
| Return on equity (ROE) |
-511.2%
|
-5.5%
|
36.2% |
| Change turnover |
-567
|
695
|
563 |
| Change turnover % |
-17%
|
25%
|
24% |
| Chg. No. of employees |
-17
|
9
|
1 |
| Chg. No. of employees % |
-74%
|
64%
|
8% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.